                         SEQUENCE LISTING

<110>  TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
       RAMBAM MED-TECH LTD.
 
<120>  METHOD FOR DETERMINING SUITABILITY TO ANTI-TNF ALPHA THERAPY

<130>  TECH-TRMB-P-0257-PCT

<150>  US 63/210,023
<151>  2021-06-13

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1
agcggctgac gtgtgcagta at                                                22


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2
cgaggggctg agacatttac aaca                                              24


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
agtttcagaa gatgaggatg atga                                              24


<210>  4
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4
aatcacagac cgtgtgtata cag                                               23


<210>  5
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5
gctggatttc ctgaagagcg atg                                               23


<210>  6
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6
cggtgaatgt agttcttccg ctc                                               23


<210>  7
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7
ggtgacttgt ccactccagt gt                                                22


<210>  8
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8
accattgagg ctccaggaac ac                                                22


<210>  9
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9
agcggctgac gtgtgcagta at                                                22


<210>  10
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10
tctgagacct ctggcttcgt ca                                                22


<210>  11
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11
ccacagacct tccaggagaa tg                                                22


<210>  12
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12
gtgcagttca gtgatcgtac agg                                               23


<210>  13
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  13
ctggaacagg tgcctaaagg ac                                                22


<210>  14
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  14
gtccagtgtc aggttatcca cc                                                22


